상세 보기
초록
Applying a next-generation sequencing assay targeting 145 cancer-relevant genes in 40 colorectal cancer and 24 non-small cell lung cancer formalin-fixed paraffin-embedded tissue specimens identified at least one clinically relevant genomic alteration in 59% of the samples and revealed two gene fusions, C2orf44-ALK in a colorectal cancer sample and KIF5B-RET in a lung adenocarcinoma. Further screening of 561 lung adenocarcinomas identified 11 additional tumors with KIF5B-RET gene fusions (2.0%; 95% CI 0.8-3.1%). Cells expressing oncogenic KIF5B-RET are sensitive to multi-kinase inhibitors that inhibit RET.
키워드
MUTATIONS; SENSITIVITY; CARCINOMAS; ACTIVATION; INHIBITOR; GEFITINIB; ERLOTINIB; CETUXIMAB; PATHWAYS; TUMORS
- 제목
- Identification of new <i>ALK</i> and <i>RET</i> gene fusions from colorectal and lung cancer biopsies
- 저자
- Lipson, Doron; Capelletti, Marzia; Yelensky, Roman; Otto, Geoff; Parker, Alex; Jarosz, Mirna; Curran, John A.; Balasubramanian, Sohail; Bloom, Troy; Brennan, Kristina W.; Donahue, Amy; Downing, Sean R.; Frampton, Garrett M.; Garcia, Lazaro; Juhn, Frank; Mitchell, Kathy C.; White, Emily; White, Jared; Zwirko, Zac; Peretz, Tamar; Nechushtan, Hovav; Soussan-Gutman, Lior; Kim, Jhingook; Sasaki, Hidefumi; Kim, Hyeong Ryul; Park, Seung-il; Ercan, Dalia; Sheehan, Christine E.; Ross, Jeffrey S.; Cronin, Maureen T.; Jaenne, Pasi A.; Stephens, Philip J.
- DOI
- 10.1038/nm.2673
- 발행일
- 2012-03
- 유형
- Article
- 저널명
- Nature Medicine
- 권
- 18
- 호
- 3
- 페이지
- 382 ~ 384
- 언어
- ENG
- 출판사
- Nature Publishing Group
- 발행국가
- 미국
- 분량
- 3 페이지
- ISSN
- E 1546-170X
P 1078-8956